Reuters logo
BRIEF-Ocular Therapeutix(Tm) starts enrollment in phase 3 clinical trial with OTX-TP
2016年10月4日 / 晚上8点22分 / 1 年内

BRIEF-Ocular Therapeutix(Tm) starts enrollment in phase 3 clinical trial with OTX-TP

Oct 4 (Reuters) - Ocular Therapeutix(Tm)

* Begins Enrollment In First Phase 3 Clinical Trial With Otx Tp (sustained release travoprost) for the treatment of glaucoma and ocular hypertension

* Says plan to commence second phase 3 clinical trial in first half of 2017

* Says expect topline results from first phase 3 clinical trial to be available in first half of 2018 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below